Cargando…

The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer

BACKGROUND: Advanced colorectal cancer (CRC), either locally advanced, metastasized (mCRC) or both, is present in a relevant proportion of patients. The chances on curation of advanced CRC are continuously improving with modern multi-modality treatment options. For incurable CRC the focus lies on pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Grossmann, Irene, Klaase, Joost M, Avenarius, Johannes KA, de Hingh, Ignace HJT, Mastboom, Walter JB, Wiggers, Theo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228755/
https://www.ncbi.nlm.nih.gov/pubmed/21982508
http://dx.doi.org/10.1186/1471-2407-11-433
_version_ 1782217864411873280
author Grossmann, Irene
Klaase, Joost M
Avenarius, Johannes KA
de Hingh, Ignace HJT
Mastboom, Walter JB
Wiggers, Theo
author_facet Grossmann, Irene
Klaase, Joost M
Avenarius, Johannes KA
de Hingh, Ignace HJT
Mastboom, Walter JB
Wiggers, Theo
author_sort Grossmann, Irene
collection PubMed
description BACKGROUND: Advanced colorectal cancer (CRC), either locally advanced, metastasized (mCRC) or both, is present in a relevant proportion of patients. The chances on curation of advanced CRC are continuously improving with modern multi-modality treatment options. For incurable CRC the focus lies on palliation of symptoms, which is not necessarily a resection of the primary tumor. Both situations motivate adequate staging before treatment in CRC. This prospective observational study evaluates the outcomes after the introduction of routine staging with abdominal CT before treatment. METHODS: In a prospective observational study of 612 consecutive patients (2007-2009), the ability of abdominal CT to find liver metastases (LM), peritoneal carcinomatosis (PC) and T4 stage in colon cancer (CC) was analysed. RESULTS: Advanced CRC was present in 58% of patients, mCRC in 31%. The ability to find LM was excellent (99%), cT4 stage CC good (86%) and PC poor (33%). In the group of surgical patients with emergency presentations, the incidences of both mCRC (51%) and locally advanced colon cancer (LACC) (69%) were higher than in the elective group (20% and 26% respectively). Staging tended to be omitted more often in the emergency group (35% versus 12% in elective surgery). CONCLUSIONS: The strengths of staging with abdominal CT are to find LM and LACC, however it fails in diagnosing PC. On grounds of the incidence of advanced CRC, staging is warranted in patients with emergency presentations as well.
format Online
Article
Text
id pubmed-3228755
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32287552011-12-02 The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer Grossmann, Irene Klaase, Joost M Avenarius, Johannes KA de Hingh, Ignace HJT Mastboom, Walter JB Wiggers, Theo BMC Cancer Research Article BACKGROUND: Advanced colorectal cancer (CRC), either locally advanced, metastasized (mCRC) or both, is present in a relevant proportion of patients. The chances on curation of advanced CRC are continuously improving with modern multi-modality treatment options. For incurable CRC the focus lies on palliation of symptoms, which is not necessarily a resection of the primary tumor. Both situations motivate adequate staging before treatment in CRC. This prospective observational study evaluates the outcomes after the introduction of routine staging with abdominal CT before treatment. METHODS: In a prospective observational study of 612 consecutive patients (2007-2009), the ability of abdominal CT to find liver metastases (LM), peritoneal carcinomatosis (PC) and T4 stage in colon cancer (CC) was analysed. RESULTS: Advanced CRC was present in 58% of patients, mCRC in 31%. The ability to find LM was excellent (99%), cT4 stage CC good (86%) and PC poor (33%). In the group of surgical patients with emergency presentations, the incidences of both mCRC (51%) and locally advanced colon cancer (LACC) (69%) were higher than in the elective group (20% and 26% respectively). Staging tended to be omitted more often in the emergency group (35% versus 12% in elective surgery). CONCLUSIONS: The strengths of staging with abdominal CT are to find LM and LACC, however it fails in diagnosing PC. On grounds of the incidence of advanced CRC, staging is warranted in patients with emergency presentations as well. BioMed Central 2011-10-07 /pmc/articles/PMC3228755/ /pubmed/21982508 http://dx.doi.org/10.1186/1471-2407-11-433 Text en Copyright ©2011 Grossmann et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Grossmann, Irene
Klaase, Joost M
Avenarius, Johannes KA
de Hingh, Ignace HJT
Mastboom, Walter JB
Wiggers, Theo
The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer
title The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer
title_full The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer
title_fullStr The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer
title_full_unstemmed The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer
title_short The strengths and limitations of routine staging before treatment with abdominal CT in colorectal cancer
title_sort strengths and limitations of routine staging before treatment with abdominal ct in colorectal cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228755/
https://www.ncbi.nlm.nih.gov/pubmed/21982508
http://dx.doi.org/10.1186/1471-2407-11-433
work_keys_str_mv AT grossmannirene thestrengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer
AT klaasejoostm thestrengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer
AT avenariusjohanneska thestrengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer
AT dehinghignacehjt thestrengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer
AT mastboomwalterjb thestrengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer
AT wiggerstheo thestrengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer
AT grossmannirene strengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer
AT klaasejoostm strengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer
AT avenariusjohanneska strengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer
AT dehinghignacehjt strengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer
AT mastboomwalterjb strengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer
AT wiggerstheo strengthsandlimitationsofroutinestagingbeforetreatmentwithabdominalctincolorectalcancer